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In nucleus, eIF4E regulates the nucleus export of speciﬁc mRNA. In this study, altered 4E-BP3 (eIF4E-
binding protein 3) expression resulted in profoundly affected cyclin D1 protein levels, partially due
to changes in the cytoplasmic cyclin D1 mRNA levels in both U2OS and MCF7 cells, whereas altered
4E-BP1 expression did not affect eIF4E-mediated cyclin D1 mRNA export. 4E-BP3 also affected a sub-
set of growth promoting mRNAs exported in an eIF4-dependent manner. Furthermore, 4E-BP3
interacted with dephosphorylated RPA2 (replication protein A2). The results indicated 4E-BP3 acts
as an inhibitor of eIF4E-mediated mRNA export in the examined cells, and 4E-BP3 inhibition of
eIF4E-mediated mRNA export is regulated by the phosphorylation state of RPA2.
Structured summary of protein interactions:
4EBP3 physically interacts with RPA2 by anti bait coimmunoprecipitation (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein synthesis is a complex, tightly regulated process in
eukaryotic cell. Translational control occurs primarily at the rate-
limiting initiation step, where ribosomal subunits are recruited
to template mRNAs through the concerted action of several
eukaryotic initiation factors (eIFs). One factor that interacts with
both the mRNA and ribosomes, and appears limiting for translation
is eIF4F.
Although eIF4E is thought to play a key role in translation initi-
ation in the cytoplasm, at least a proportion of eIF4E is found in the
nucleus, and nuclear eIF4E, like the cytoplasmic fraction of eIF4E,
has been demonstrated to bind the m7G cap. Recently, Keene pro-
posed the RNA regulon theory (also known as the RNA operon) [1],
which states that genes can be post-transcriptionally coordinated
by controlling mRNA splicing, export, localization, translational
efﬁciency, and stability. In the cytoplasm, eIF4E represents the
rate-limiting step of translation initiation; whereas in the nucleus,
eIF4E forms nuclear bodies and plays a role in the nucleocytoplas-chemical Societies. Published by E
Biochemistry and Molecular
ational Cheng Kung Univer-
6 6 275 4697.
. Chang).mic export of a subset of growth-promoting mRNAs, such as cyclin
D1, murine double minute 2 (MDM2), and Nijmegen breakage syn-
drome 1 (NBS1) [2,3].
The eIF4E-binding proteins (4E-BP1, 4E-BP2, and 4E-BP3) [4,5]
are well known for regulating the activity of eIF4E. Of the three
4E-BPs, 4E-BP1 is the best characterized. Although 4E-BP3 shares
the basic structural and functional features of 4E-BP1 and 4E-
BP2, some of the properties of 4E-BP3 appear to be unique [5]. First,
the tissue expression of the 4E-BP3 mRNA differs from that of 4E-
BP1 and 4E-BP2 [5]. Second, a regulatory motif of four amino acids
(RAIP motif) in the N-terminus of 4E-BP1 and 4E-BP2, which is crit-
ical for phosphorylation of 4E-BP1 and 4E-BP2 at mTOR-regulated
sites [6], is absent from 4E-BP3. Third, Kleijn et al. [7] reported that
signiﬁcant amounts of 4E-BP3 are detected in nuclear fractions of a
variety of cell types. Based on the observations that nuclear eIF4E
controls the expression of certain growth stimulatory proteins by
regulating mRNA export from the nucleus and that 4E-BP3 has
been demonstrated to bind eIF4E in the nucleus [7], we hypothe-
sized that 4E-BP3 might be involved in the regulation of eIF4E-
mediated nucleocytoplasmic transport.
Replication protein A (RPA) is a eukaryotic single-stranded
DNA (ssDNA)-binding protein that is essential for DNA replica-
tion, DNA repair, and DNA recombination and has important
functions in DNA damage signaling. Human RPA is a heterotri-lsevier B.V. All rights reserved.
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32 kDa), and small (RPA3, 14 kDa) subunits [8]. RPA activity in
DNA metabolism is regulated by changes in the pattern of RPA2
phosphorylation; RPA2 is phosphorylated during the course of
the cell cycle, including the G/S transition, G2, and M-phase. Upon
DNA damage, RPA2 becomes hyperphosphorylated and hyper-
phosphorylation of RPA2 is associated with the cessation of
cell-cycle progression, decreased RPA involvement in replication,
and subsequent DNA repair [9].
In this study, we examined the expression of 4E-BP3 and its
localization in various human cell lines and provided evidence that
4E-BP3 altered eIF4E-mediated mRNA export based on downregu-
lation or overexpression of 4E-BP3 in our examined cells. In addi-
tion, we demonstrated that RPA2 is a new 4E-BP3 interacting
protein; RPA2 binds with 4E-BP3 through its N-terminal domain,
which was hyperphosphorylated in response to DNA-damaging
agents. Furthermore, we also found that the RPA2/4E-BP3 complex
disappeared after cells were exposed to UV light, suggesting a reg-
ulatory pathway for the control of eIF4E-mediated export that is
unique to nuclear 4E-BP3.2. Materials and methods
The details are provided in Supplementary data.
3. Results
3.1. 4E-BP1 and 4E-BP3 expression and distribution in human cell lines
To investigate whether 4E-BP1 and 4E-BP3 expressed in human
cells or not, RT-PCR was performed on a variety of cell lines. The
results (Fig. 1A, left panel) showed that both of the mRNAs were
detected in all nine human cell lines assayed. Several studies have
reported that 4E-BP1 localization is restricted to the cytoplasm
[10]. However, using new 4E-BP1 antibodies (53H11; Cell Signaling
Technology), Rong et al. recently reported that a sizeable fraction
of endogenous 4E-BP1 is localized to the nucleus in various cell
types [11]. We therefore examined the distribution of endogenous
4E-BP1 and 4E-BP3 in U2OS and MCF7 cells. The results revealed
that approximately 23–25% of endogenous 4E-BP1 was detected
in the nucleus, whereas at least 42–45% of 4E-BP3 was observed
in the nucleus of both cell lines (Fig. 1A, middle and right panels).
3.2. Comparison of 4E-BP3 and 4E-BP1 in cap-dependent translation
efﬁciency
To elucidate the 4E-BP3 function, we ﬁrst examined whether
4E-BP3 had the same inhibiting effect as 4E-BP1 on cap-dependent
translation or not. In vivo translation assays were performed using
the pGL3-promoter reporter to analyze repression of cap-depen-
dent translation by 4E-BP1 or 4E-BP3. The results showed that an
inhibition of cap-dependent translation by the 4E-BP3 seems to
be similar to 4E-BP1 (Fig. 1B).
3.3. 4E-BP3. represses eIF4E-mediated mRNA transport
Although Rong et al. demonstrated that about 30% of 4E-BP1 is
located in the nucleus [11], they did not address whether or not
4E-BP1 could repress eIF4E-mediated mRNA nucleoplasmic ex-
port. Culjkovic et al. had demonstrated that nuclear eIF4E exports
many mRNAs involved in cell-cycle progression, including cyclin
D1 and MDM2 [3].Consequently, we analyzed the effect of reduc-
ing endogenous 4E-BP3 or 4E-BP1 (via siRNAs) on cyclin D1 pro-
tein and mRNA levels in U2OS cells. The results revealed that
cyclin D1 protein levels were increased 25% and 79% in 4E-BP1knockdown cells and 4E-BP3 knockdown cells, respectively
(Fig. 1C, left panel). siRNA treatment against 4E-BP1 resulted in
downregulation of the 4E-BP1 protein (by approximately 64%;
Fig. 1C, left panel) and mRNA (by approximately 65%; Fig. 1C,
middle panel) and had no effect on the expression of 4E-BP3. Fur-
thermore, siRNA to 4E-BP3 resulted in downregulation of 4E-BP3
protein (by approximately 65%; Fig. 1C, left panel) and mRNA (by
approximately 60%; Fig. 1C, middle panel) and had no effect on
the expression of 4E-BP1. Together, these results suggested the
absence of any regulatory cross talk between 4E-BP1 and 4E-
BP3. To determine whether eIF4E-dependent cyclin D1 mRNA
transport is modulated by 4E-BP1 or 4E-BP3, the cells treated
with 4E-BP1 siRNA, 4E-BP3 siRNA, or scramble siRNA and the
subcellular distribution of cyclin D1 mRNA was assayed. The re-
sults revealed that the relative amount of total cyclin D1
mRNA/actin mRNA remained unchanged irrespective of 4E-BP3
or 4E-BP1 knockdown (Fig. 1C, middle panel). However, it was
observed that cytoplasmic cyclin D1 mRNA levels increased
(about 70%) in 4E-BP3 knockdown cells, whereas cytoplasmic cy-
clin D1 mRNA levels were unchanged in 4E-BP1 knockdown cells
(Fig. 1C, right panel).
To investigate whether overexpression of 4E-BP1 or 4E-BP3
could affect cytoplasmic cyclin D1 mRNA level, U2OS cells were
transiently transfected with pcDNA3.1B (vector only), Myc-BP1
or Myc-BP3 and cyclin D1 protein and mRNA levels were deter-
mined. The results showed that in comparison to the control cells,
cyclin D1 protein levels were decreased to 72% and 64% in ectopic
4E-BP1-expressing cells and ectopic 4E-BP3-expressing cells,
respectively (Fig. 1D, left panel), although the relative amount of
total cyclin D1 mRNA/actin mRNA remained unchanged in both
cell lines (Fig. 1D, middle panel). In addition, it was observed that
cytoplasmic cyclin D1 mRNA levels decreased by 60% in ectopic 4E-
BP3-expressing cells (P < 0.05), whereas cytoplasmic cyclin D1
mRNA levels were statistically insigniﬁcant change (P > 0.01) in ec-
topic 4E-BP1-expressing cells (Fig. 1D, right panel). These data re-
vealed that altered 4E-BP3 expression, either by siRNA knockdown
or ectopic expression of 4E-BP3, resulted in profoundly affected cy-
clin D1 protein levels and that this effect was at least partly due to
change in the cytoplasmic levels of the cyclin D1 mRNA. In con-
trast, although altered 4E-BP1 expression also affected cyclin D1
protein levels, its effect was not mediated by changes in the cyto-
plasmic levels of the cyclin D1 mRNA.
To further conﬁrm that ectopic expression of 4E-BP3 could af-
fect the cytoplasmic cyclin D1 mRNA levels, we established
U2OS-derived (Fig. 2) and MCF7-derived (Supplementary Fig. 1A)
cell lines that stably expressed 4E-BP3 proteins. The results
showed that decreased levels of the cyclin D1 protein were present
in U2OS-derived cells that stably expressed 4E-BP3, SBP3-U1 and
SBP3-U5, when compared to the control cells, pc-1 (Fig. 2A, left pa-
nel). Ectopic expression of 4E-BP3 [SBP3-U1, SBP3-U5 (4E-BP3 sta-
bly expressed in U2OS cells) and SBP3-M1 (4E-BP3 stably
expressed in MCF7 cell)] led to diminished cell proliferation com-
paring to pc-1 cells (Fig. 2A, middle panel and Supplementary
Fig. 1A). As shown in Fig. 2A (right panel), knockdown of 4E-BP3
in pc-1 cells resulted in increased cyclin D1 protein levels, which
was similar to the above studies in U2OS cells. In addition, the de-
creased cyclin D1 protein level observed in SBP3-U1 cells could be
partially rescued by knockdown of 4E-BP3. Consistent with previ-
ous results, total cyclin D1 mRNA levels were unchanged in these
established cells (Fig. 2B, left panel), whereas cytoplasmic cyclin
D1 mRNA levels were decreased by 50% in SBP3-U1 cells and by
25% in SBP3-U5 cells (Fig. 2B, middle panel). Similarly, it was also
observed that cytoplasmic cyclin D1 mRNA levels were decreased
by about 60% in MCF-7-derived cells stably expressing 4E-BP3
(Supplementary Fig. 1B), but total cyclin D1 mRNA levels were un-
changed in these established cells (Supplementary Fig. 1B).
Fig. 1. The function and expression levels of 4E-BP3 and 4E-BP1. (A) Analyze expression and distribution of 4E-BP3 and 4E-BP1 in various cells. The mRNA levels of 4E-BP3
and 4E-BP1 were determined by RT-PCR in various cell lines (left panel), including ﬁve breast cancer cell lines (T47D, ZR75-1, MCF7, MDA-MB-435S [435S], and MDA-MB-231
[231]), one hepatoma cell line (HepG2), one osteosarcoma (U2OS), and two colon cancer cell lines (HT-29 and SW620). The distribution of endogenous 4E-BP1 and 4E-BP3
was determined by Western blot in U2OS (middle panel) and MCF7 cells (left panel). Cytoplasmic and nuclear fractions of U2OS and MCF7 cells were analyzed by SDS–PAGE
and Western blot using 4E-BP3, 4E-BP1(53H11; Cell Signaling Technology), tubulin (as cytoplasmic marker) and lamin B (as nuclear marker). (B) Analyze inhibition of cap-
dependent translation by 4E-BP3 and 4E-BP1. 293T cells were cotransfected with 0.5 lg of the pGL3-promoter plasmid containing a ﬁreﬂy luciferase reporter (cap-dependent
translation), 0.5 lg of pIRES-luc plasmid containing Renilla luciferase (cap-independent translation) and 2 lg of myc-4E-BP1, myc-4E-BP3 or pcDNA3.1B(vector only) plasmid.
After 48 h, luciferase activity (left panel) was determined. Results are presented as mean ± S.D. of three independent experiments, and each experiment was performed in
duplicate. ⁄⁄⁄ mean P < 0.001. Western blot using c-myc antibodies were used to determine 4E-BP1 and 4E-BP3 the expression level and b-actin was loading control. The
results of Western blot showed that two transfected 293T cells were able to express comparable level of exogenous 4E-BP1 and 4E-BP3 respectively. (C) Effects of
downregulation of 4E-BP3 and 4E-BP1 on cyclin D1 protein and mRNA levels. U2OS cells were transiently transfected with 100 nM scramble, 4E-BP1 (siBP1), or 4E-BP3
(siBP3) siRNA. After 48 h, whole cell lysates were collected, subjected to 12% SDS–PAGE, and immunoblotted with 4E-BP1, 4E-BP3, cyclin D1 and b-actin antibodies (left
panel). A total of 1 lg total (middle panel) and cytoplasmic RNA (right panel) was used to perform real-time RT-PCR using primers for 4E-BP1, 4E-BP3, cyclin D1, and b-actin.
The relative expression of 4E-BP1, 4E-BP3, and cyclin D1 mRNA was normalized to b-actin mRNA levels. Vertical bars represent mean ± S.D. from three independent
experiments. ⁄ P < 0.05 versus scrambled siRNA cells. RT-PCR analysis of tRNALys (as cytoplasmic marker) and U6 snRNA (as nuclear marker) veriﬁed that nuclear RNA did not
leak into cytoplasmic fraction during isolation procedures. (D) Effect of ectopic expression of 4E-BP3 or 4E-BP1 on cyclin D1 protein and mRNA levels. U2OS cells were
transiently transfected with 2 lg the pcDNA3.1B (vector only), pcDNA3.1B-4E-BP1 (Myc-BP1), or pcDNA3.1B-4E-BP3 (Myc-BP3) plasmid. After 48 h, whole cell lysates of
transfected cells were extracted, separated by 12% SDS–PAGE, and then subjected to immunoblotting (left panel) using cyclin D1, c-Myc, and b-actin antibodies. Exogenous
4E-BP1 and 4E-BP3 was detected using c-Myc antibodies. b-actin was used as a loading control. Total (middle panel) and cytoplasmic (right panel) cyclin D1 mRNA levels
were determined by real-time RT-PCR. The levels of cyclin D1 mRNA were normalized to b-actin mRNA levels. Vertical bars represent mean ± S.D. from three independent
experiments. ⁄ P < 0.05 versus scrambled pcDNA3.1B-transfected cells.
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Fig. 2. The inﬂuence of 4E-BP3 on eIF4E’s export function. (A) Elevated 4E-BP3 expression decreased cyclin D1 protein levels in U2OS cells (left panel). Cell lysates (50 lg)
from U2OS cells stably expressing Myc-BP3 clones (SBP3-U1 and SBP3-U5) or an empty vector clone (pc-1) were subjected to Western blot analysis using antibodies speciﬁc
to c-Myc, cyclin D1, and b-actin. Repression of the cyclin D1 protein was rescued by downregulation of 4E-BP3 levels (right panel). Ectopic expression of 4E-BP3 (SBP3-U1 and
SBP3-U5) led to reduced cell proliferation comparing to pc-1 cells (middle panel). Cell growth was analyzed using MTT method. Rescue of cyclin D1 protein levels by 4E-BP3
downregulation via 4E-BP3 siRNA (right panel). The pc-1 and SBP3-U1 cells were transiently transfected with 100 nM of scramble or 4E-BP3 siRNA, and cells were harvested
for Western blot analysis using c-Myc, cyclin D1, and b-actin antibodies. (B) 4E-BP3 overexpression diminished cytoplasmic cyclin D1 mRNA levels. Total (left panel) and
cytoplasmic RNA (right panel) was extracted from pc-1, SBP3-U1, and SBP3-U5 cells. Total and cytoplasmic RNA (1 lg) were then used to perform real-time RT-PCR
experiments using primers for cyclin D1 and b-actin. The relative levels of cyclin D1 were normalized to b-actin mRNA levels. Vertical bars represent the mean ± S.D. from
three independent experiments carried out in triplicate. ⁄⁄⁄ P < 0.001 SBP3-U1 versus pc-1. (C) Rescue of cyclin D1 protein expression by wild-type eIF4E and translation-
deﬁcient eIF4E (eIF4EW73A), but not by m7G-cap–binding deﬁcient eIF4E (eIF4EW56A). SBP3-U1 cells were transfected with FLAG-eIF4Ewt (wild-type eIF4E), FLAG-eIF4EW73A
(translation-deﬁcient mutant), or FLAG-eIF4EW56A (m7G-cap binding mutant). After 48 h, whole cell extracts were prepared, resolved by 12% SDS–PAGE, and blotted with
antibodies speciﬁc for cyclin D1, FLAG, c-myc, and b-actin (left panel). Total (middle panel) and cytoplasmic RNA (right panel) was extracted from pc-1 cells transfected with
p3XFlag and SBP3-U1 cells transfected with p3XFlag, FLAG-eIF4Ewt, FLAG-eIF4EW73A, or FLAG-eIF4EW56A and then analyzed for cyclin D1 mRNA levels using real-time RT-PCR.
The relative levels of cyclin D1 were normalized to b-actin mRNA levels. Vertical bars represent the mean ± S.D. from three independent experiments performed in triplicate.
⁄⁄ P < 0.005 SBP3-U1 transfected with FLAG-eIF4Ewt or FLAG-eIF4EW73A versus SBP3-U1 cells transfected with p3XFlag. RT-PCR analysis of tRNALys and U6 snRNA indicated
that nuclear RNA did not leak into cytoplasmic fraction during isolation procedures. (D) 4E-BP3 overexpression impeded eIF4E-dependent nuclear export of sensitive RNA
transcripts. Total (left panel) and cytoplasmic (middle panel) RNA was isolated from pc-1, SBP3-U1, and SBP3-U5 cells, and NBS1, MDM2, eIF4E and GAPDHmRNA levels were
determined by real-time RT-PCR. Each sample was normalized to b-actin expression. Vertical bars represent mean ± S.D. from three independent experiments performed in
triplicate. ⁄⁄⁄ P < 0.001 SBP3-U1 versus pc-1 cells. Elevated 4E-BP3 levels resulted in decreased NBS1 protein expression (right panel). Total protein was extracted from pc-1,
SBP3-U1, and SBP3-U5 cells and then subjected to Western blot analysis using NBS1, eIF4E, c-Myc, GAPDH and b-actin antibodies.
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Fig. 3. In vivo and in vitro RPA2/4E-BP3 interactions. (A) Endogenous RPA2–4E-BP3 complex was detected in both the U2OS and MCF7 cells. Lysates from U2OS or MCF7 cells
were immunoprecipitated (IP) using either 4E-BP1, 4E-BP3 or IgG antibodies, followed by immunoblotting (IB) with RPA2 antibodies. Ten percent of the whole cell lysates as
an input control was analyzed by Western blot using 4E-BP1, 4E-BP3 and b-actin antibodies. (B) In vitro translated protein was used to show the interaction between 4E-BP3
and RPA2. Diagram of full length RPA2 (RPA2FL) and the two truncated fragments of RPA2 (RPA235–270 and RPA21–170) was used in this assay (left panel). In vitro translated
35S-labeled 4E-BP3 was incubated with 35S-labeled RPA2 (35S-labeled 4E-BP3 lysates and vector lysates served as positive and negative controls, respectively), 4E-BP3
antibodies, and protein A-Sepharose beads at 4 C for 16 h. The beads were washed, boiled, and separated using 15% SDS–PAGE followed by autoradiography. Five percent of
the in vitro translated protein was used as an input control. Mapping the 4E-BP3 interacting domain of RPA2 was performed by in vitro co-immunoprecipitation assays (right
panel). (C) The interaction between 4E-BP3 and RPA2 was dissociated after UV exposure. U2OS cells were treated with UV light (50 J/m2) and then collected and lysed at 0, 1,
and 2 h after treatment. Whole cell lysates (500 lg) were immunoprecipitated (IP: 4E-BP3) using 4E-BP3 antibodies followed by immunoblotting with RPA2 antibodies. A
total of 10% of whole cell lysates (50 lg) was analyzed by Western blot as an input control using RPA2, 4E-BP3 and b-actin antibodies. RPA2 became phosphorylated after UV
exposure. Phosphorylated RPA2 is indicated as RPA2-P. (D) The repression of the cyclin D1 protein was enhanced by RPA2 knockdown. pc-1 and SBP3-U1 cells were
transiently transfected with 100 nM scrambled () or RPA2 (+) siRNA (left panel). After 48 h, whole cell lysates were collected, subjected to 12% SDS–PAGE, and
immunoblotted with antibodies speciﬁc to c-Myc, cyclin D1, RPA2, and b-actin. The repression of cyclin D1 protein in RPA2 knockdown cells was rescued by 4E-BP3 and RPA2
double knockdown (right panel). pc-1 and SBP3-U1 cells were transiently transfected with 100 nM scrambled () or RPA2, 4E-BP3 (+) siRNA. After 48 h, whole cell lysates
were analyzed by Western blot using cyclin D1, RPA2, c-Myc, and b-actin antibodies.
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by ectopic expression of 4E-BP3 was mediated via its interaction
with eIF4E, parallel studies were carried out with two mutants of
eIF4E: eIF4EW73A, which functions in mRNA export but is impaired
in its translation function [2,3], and an eIF4EW56A, which is notfunctional for m7G cap-binding [3,12]. As shown in Fig. 2C,
decreased cytoplasmic cyclin D1 mRNA levels in SBP3-U1 cells
could be rescued by transient transfection of wild-type eIF4E or
eIF4EW73A. This is consistent with previous studies [2,3] showing
that eIF4EW73A had similar cyclin D1 mRNA transport activity as
C.-C. Chen et al. / FEBS Letters 586 (2012) 2260–2266 2265the wild-type protein. As expected, cytoplasmic cyclin D1 mRNA
levels were not altered in SBP3-U1 cells transfected with
eIF4EW56A. These results further demonstrated that 4E-BP3 plays
a role in regulating eIF4E-mediated cyclin D1 mRNA transport.
The inﬂuence of 4E-BP3 on the export of other eIF4-dependent
mRNAs, such as MDM2 and NBS1, as well as eIF4E-independent
mRNAs, such as eIF4E and GAPDH [3], were also analyzed. Cytoplas-
mic MDM2 and NBS1 mRNAs were signiﬁcantly reduced in SBP3-
U1 cells (Fig. 2D, middle panel) compared to pc-1 cells; however,
cytoplasmic eIF4E and GAPDH mRNA levels remained unchanged
(Fig. 2D, middle panel). In addition, total amounts of mRNAs re-
mained unchanged in these cells (Fig. 2D, left panel). Incidentally,
NBS1 protein levels were decreased to 54% and 65% in SBP3-U1
and SBP3-U5 cells, respectively, but eIF4E and GAPDHprotein levels
remained unchanged (Fig. 2D, right panel). Taken together, these
data showed that 4E-BP3 played a role in regulating eIF4E-medi-
ated mRNA export from the nucleus in the examined cells.
3.4. Identiﬁcation of a 4E-BP3-interacting protein
Next, to identify proteins that interacted with 4E-BP3, a human
mammary gland cDNA library was screened using the yeast two-
hybrid system with 4E-BP3 as the bait. Database searching
revealed that one of the positive clones encoded the full-length
human RPA2. To examine whether RPA2 is able to interact with
4E-BP3 in mammalian cells, a vector containing 4E-BP1 or 4E-
BP3 was transfected into human 293T cells, and then coimmuno-
precipitated analysis was performed. The results showed that
RPA2 were speciﬁcally coimmunoprecipitated with 4E-BP3 but
not with 4E-BP1 (Supplementary Fig. 2). To further conﬁrm the
interaction between 4E-BP3 and RPA2, in vivo co-immunoprecipi-
tation was performed. As shown in Fig. 3A, RPA2 was co-immuno-
precipitated with 4E-BP3 but not with 4E-BP1 in both U2OS and
MCF7 cells. In addition, the results of in vitro immunoprecipitation
experiments also revealed that RPA2 could speciﬁcally bind with
4E-BP3 (Fig. 3B, right panel). To further map the domain of RPA2
that mediated the interaction with 4E-BP3, we tested individual
domains from RPA2 against full-length 4E-BP3 using in vitro
immunoprecipitation assays. Our results indicated that the
N-terminal 1–170 amino acid residues of RPA2 exhibited strong
binding to 4E-BP3 (Fig. 3B).
In light of the fact that the N-terminal residues of RPA2 contain
several phosphorylation sites, we then analyzed whether the phos-
phorylated form of RPA2 possessed 4E-BP3-binding capacity. Since
RPA2 phosphorylation can be induced by ultraviolet (UV) light, we
examined whether the RPA2/4E-BP3 complex could be detected
after treating these cells with UV light (50 J/m2 after 1 h). The re-
sults showed that the RPA2/4E-BP3 interaction disappeared after
the cells were exposed to UV light, suggesting that phosphorylated
RPA2 could not interact with 4E-BP3 (Fig. 3C).
3.5. The effect of RPA2 on the 4E-BP3–mediated decrease in cyclin D1
Because ectopic 4E-BP3 could reduce cyclin D1 levels by inhib-
iting eIF4E-mediated mRNA export and RPA2 is a 4E-BP3-inter-
acting protein, we analyzed the effect of ectopic RPA2
expression on cyclin D1 expression. Since the high abundance
of endogenous RPA2 in cells, we examined whether cyclin D1
expression could be affect by knockdown of RPA2. The results re-
vealed that the cyclin D1 protein was signiﬁcantly reduced upon
silencing of RPA2 using a siRNA approach (Fig. 3D, left panel),
whereas the repression of cyclin D1 in RPA2-knockdown cells
could be rescued upon simultaneous silencing RPA2 and 4E-BP3,
suggesting that downregulation of RPA2 led to generation of more
free 4E-BP3 to bind with eIF4E, thus reducing mRNA transport by
eIF4E.4. Discussion
Of all 4E-BPs, 4E-BP3 was the last one to be identiﬁed, and the
regulation and biological function of 4E-BP3 remains largely
unclear. Here, we found that both the 4E-BP1 and 4E-BP3 mRNAs
are expressed in all nine of the human cell lines examined. Further-
more, 4E-BP3 seems to exhibit the same effect on inhibition of
cap-dependent translation as 4E-BP1. These data raised the ques-
tion as to why both 4E-BP1 and 4E-BP3 exist within the same cell
if 4E-BP3 appears to have the same effect on inhibition of cap-
dependent translation as 4E-BP1. In the present study, we showed
for the ﬁrst time that 4E-BP3 altered eIF4E-mediated mRNA export
when overexpressed or downregulated in the examined cells. The
altered cytoplasmic cyclin D1 mRNA level was dependent on bind-
ing of eIF4E and 4E-BP3, since the overexpression ofwild-type eIF4E
or the eIF4EW73A mutant led to increased cytoplasmic cyclin D1
mRNA levels, whereas there was no increase in cytoplasmic cyclin
D1mRNA levels when the cap-binding mutant eIF4EW56A was over-
expressed. In addition, the amounts of two other eIF4E-sensitive
mRNAs, MDM2 and NBS1, were also decreased in the cytoplasmic
fraction of 4E-BP3 overexpressing cells compared to controls. These
results suggested that 4E-BP3, in addition to inhibiting cap-depen-
dent translation similar to 4E-BP1, could also execute its function by
modulating eIF4E mRNA export in the examined cells.
We observed that 4E-BP1 is present in both the nucleus and the
cytoplasm in various cell lines, which is consistent with the ﬁnd-
ings of Rong et al. [11]. However, in contrast to 4E-BP3, neither
overexpression of 4E-BP1 nor downregulation of 4E-BP1 signiﬁ-
cantly altered production of the cytoplasmic cyclin D1 mRNA,
although cyclin D1 protein levels could be altered. This result
was consistent with the ﬁnding of Averous et al. who reported that
4E-BP1–impaired cyclin D1 expression was not associated with de-
creased mRNA export [13]. Presently, it is unclear why 4E-BP3 but
not 4E-BP1 could alter eIF4E-mediated cyclin D1 mRNA export
when overexpressed or downregulated, but this ﬁnding suggests
that in comparison to 4E-BP1, 4E-BP3 may play a specialized role
in modulating eIF4E-mediated mRNA transport function in the nu-
cleus in our examined cells.
The identiﬁcation of RPA2 as a new interaction partner of 4E-
BP3 is an interesting ﬁnding. The interaction between 4E-BP3
and RPA2 is speciﬁc, as demonstrated by the inability of the 4E-
BP1 to associate with RPA2. In addition, we also observed that
the RPA2/4E-BP3 complex dissociated when RPA2 became phos-
phorylated. Since RPA2 phosphorylation negatively regulates the
role of RPA in DNA replication and is likely to be involved in
DNA repair, and since our ﬁndings that 4E-BP3 interacted with
RPA2 and that the RPA2/4E-BP3 complex dissociated when RPA2
became phosphorylated, we propose that under normal circum-
stances the association between 4E-BP3 and eIF4E or 4E-BP3 and
RPA2 maintains homeostasis. When cells are exposed to replica-
tion stress or DNA damage, RPA2 becomes phosphorylated
[14,15], resulting in a concomitant decrease in association of
RPA2 and 4E-BP3, leading to an increased association between
4E-BP3 and eIF4E. This would result in diminished levels of cyto-
plasmic-speciﬁc transcripts transported by eIF4E, such as cyclin
D1 mRNA. Thus, we suggest that 4E-BP3 in our examined cells acts
as a negative regulator of eIF4E-mediated mRNA export that is par-
ticularly signiﬁcant under conditions of replication stress or DNA
damage, which causes RPA2 to be phosphorylated.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.febslet.2012.
05.059.
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